A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
Public ClinicalTrials.gov record NCT00353808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Trial Assessing The Safety And Tolerability Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the long-term safety and tolerability of \[S,S\]-Reboxetine in patients with chronic pain following shingles. This is the extension study of Protocol A6061026.
Study identification
- NCT ID
- NCT00353808
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2007 (Actual)
- Last update posted
- Apr 7, 2011
2006 – 2007
United States locations
- U.S. sites
- 57
- U.S. states
- 22
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Chandler | Arizona | 85225 | — |
| Pfizer Investigational Site | Gilbert | Arizona | 85234 | — |
| Pfizer Investigational Site | Sun City | Arizona | 85351 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85741 | — |
| Pfizer Investigational Site | Arcadia | California | 91007 | — |
| Pfizer Investigational Site | Fullerton | California | 92835 | — |
| Pfizer Investigational Site | Irvine | California | 92618 | — |
| Pfizer Investigational Site | Laguna Hills | California | 92653 | — |
| Pfizer Investigational Site | Loma Linda | California | 92354 | — |
| Pfizer Investigational Site | Redondo Beach | California | 90277 | — |
| Pfizer Investigational Site | Boulder | Colorado | 80304 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33765 | — |
| Pfizer Investigational Site | Fort Myers | Florida | 33912 | — |
| Pfizer Investigational Site | Holly Hill | Florida | 32117 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Kissimmee | Florida | 34741 | — |
| Pfizer Investigational Site | Largo | Florida | 33770 | — |
| Pfizer Investigational Site | Longwood | Florida | 32779 | — |
| Pfizer Investigational Site | Ocala | Florida | 34471 | — |
| Pfizer Investigational Site | Ormond Beach | Florida | 32174 | — |
| Pfizer Investigational Site | Palm Beach Gardens | Florida | 33418 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Oak Brook | Illinois | 60523 | — |
| Pfizer Investigational Site | Topeka | Kansas | 66606 | — |
| Pfizer Investigational Site | Ruston | Louisiana | 71270 | — |
| Pfizer Investigational Site | Towson | Maryland | 21286 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02215 | — |
| Pfizer Investigational Site | Brockton | Massachusetts | 02301 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48104 | — |
| Pfizer Investigational Site | Independence | Missouri | 64055 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64114 | — |
| Pfizer Investigational Site | Nixa | Missouri | 65714 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65807 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Amherst | New York | 14226 | — |
| Pfizer Investigational Site | New York | New York | 10003 | — |
| Pfizer Investigational Site | Orchard Park | New York | 14127 | — |
| Pfizer Investigational Site | Asheville | North Carolina | 28806 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27607-6520 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58103 | — |
| Pfizer Investigational Site | Canfield | Ohio | 44406 | — |
| Pfizer Investigational Site | Kettering | Ohio | 45429 | — |
| Pfizer Investigational Site | Youngstown | Ohio | 44504 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | 18103 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | 16635-0909 | — |
| Pfizer Investigational Site | Jackson | Tennessee | 38305 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Houston | Texas | 77024 | — |
| Pfizer Investigational Site | Houston | Texas | 77063 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Spokane | Washington | 99204 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00353808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2011 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00353808 live on ClinicalTrials.gov.